
欧洲无创心输出量监测设备市场预测至 2027 年 - COVID-19 影响和设备区域分析(贴片、手表、探头和导管)、适应症(高血压、冠心病、先天性问题、心肌缺血和梗塞、心力衰竭) 、心律失常等)和最终用户(医院、紧急服务中心、家庭护理等)
No. of Pages: 141 | Report Code: TIPRE00022789 | Category: Life Sciences
No. of Pages: 141 | Report Code: TIPRE00022789 | Category: Life Sciences
心输出量 (CO) 的测量在医疗实践中至关重要。过去,肺动脉导管 (PAC) 的侵入性监测是测量 CO 的黄金标准,但近年来,已经开发出许多微创或无创设备来测量 CO。心输出量提供有关组织灌注和氧气输送,可以识别死亡或发病风险较高的患者。
欧洲无创心输出量监测设备市场预计将从2020年的68,443,560美元增至2027年的94,406,570美元;预计2020年至2027年复合年增长率为4.7%。市场的增长归因于一些关键驱动因素,例如老年人口的增加以及创新监测设备的开发和推出。然而,该设备的高成本阻碍了市场的增长。
近年来,已经开发了许多微创或无创设备来测量心输出量(CO)、这在医疗实践中至关重要。心输出量提供有关组织灌注和氧气输送的信息,并可以识别死亡或发病风险较高的患者。此外,老年人口容易罹患许多慢性疾病。他们大多患有糖尿病、心脏病、肺病等多种疾病,有的还要接受手术。无创心输出量 (CO) 监测是观察危重患者时使用的重要现代医疗实践之一。根据《世界人口展望:2019 年修订版》的数据,到 2050 年,全球每 6 人中就有 1 人年龄在 65 岁以上,而 2019 年这一数字为十分之一。因此,预计 65 岁及以上人口到2050年,这一比例将从2019年的9%上升到16%。因此,老年人口的增加有利于欧洲无创心输出量监测设备市场的增长。此外,市场上的许多参与者都专注于开发和推出新产品,作为扩大地理覆盖范围和能力以满足许多客户的战略的一部分。此类新产品的开发和推出很可能成为未来几年的主要市场趋势。
欧洲 COVID-19 大流行的影响略微限制了医疗行业的发展。器件行业。多家公司已停止生产。因此,他们无法生产以满足不断增长的需求。此外,重要设备和消耗品供应停滞。然而,对其他国家供应商的依赖已经变成了医疗器械及其耗材的漫长交付过程。因此,一些医疗公司无法满足各国对医疗设备和个人防护设备的需求。因此,预计未来几年欧洲无创心输出量监测设备市场的增长可能会放缓。
>
按设备划分,欧洲无创心输出量监测设备市场分为贴片、手表、探针和探头。导管。探头和导管细分市场在 2019 年占据最大市场份额。然而,预计手表细分市场在预测期内的复合年增长率最高。
根据迹象,欧洲无创心输出量监测设备市场细分为高血压、冠心病、先天性问题、心肌缺血和梗塞、心力衰竭、心律失常等。高血压细分市场在 2019 年占据了最大的市场份额。然而,预计心力衰竭细分市场在预测期内的复合年增长率最高。
基于最终用户方面,欧洲无创心输出量监测设备市场分为医院、紧急服务中心、家庭护理等。 2019 年,医院细分市场占据最大市场份额。然而,预计紧急服务中心细分市场在预测期内的复合年增长率最高。
  ;
一些与本欧洲无创心输出量监测设备市场报告相关的主要和次要来源是欧盟 (EU)、欧洲心脏网络 (EHN)、西班牙心脏基金会 (FEC) 和意大利国家卫生服务中心 (INHS)。
Strategic insights for Europe Non-Invasive Cardiac Output Monitoring Device involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2020 | US$ 68,443.56 thousand |
Market Size by 2027 | US$ 94,406.57 thousand |
Global CAGR (2020 - 2027) | 4.7% |
Historical Data | 2018-2019 |
Forecast period | 2021-2027 |
Segments Covered |
By 设备
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Non-Invasive Cardiac Output Monitoring Device refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Non-Invasive Cardiac Output Monitoring Device Market is valued at US$ 68,443.56 thousand in 2020, it is projected to reach US$ 94,406.57 thousand by 2027.
As per our report Europe Non-Invasive Cardiac Output Monitoring Device Market, the market size is valued at US$ 68,443.56 thousand in 2020, projecting it to reach US$ 94,406.57 thousand by 2027. This translates to a CAGR of approximately 4.7% during the forecast period.
The Europe Non-Invasive Cardiac Output Monitoring Device Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Non-Invasive Cardiac Output Monitoring Device Market report:
The Europe Non-Invasive Cardiac Output Monitoring Device Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Non-Invasive Cardiac Output Monitoring Device Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Non-Invasive Cardiac Output Monitoring Device Market value chain can benefit from the information contained in a comprehensive market report.